1. Preliminary Study on the Combination Effect of Clindamycin and Low Dose Trimethoprim-Sulfamethoxazole on Severe Pneumocystis Pneumonia After Renal Transplantation
   Zhun-Yong Gu et al, 2022, Frontiers in Medicine CrossRef
2. Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality
   Yogita Singh et al, 2019, Journal of Global Antimicrobial Resistance CrossRef
3. Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
   Thomas R Rogers et al, 2022, Journal of Antimicrobial Chemotherapy CrossRef
4. Genetic polymorphisms associated with treatment failure and mortality in pediatric Pneumocystosis
   Yogita Singh et al, 2019, Scientific Reports CrossRef
5. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey
   Soykan Ozkoc et al, 2018, Parasitology Research CrossRef
6. Therapy and Management of Pneumocystis jirovecii Infection
   P. White et al, 2018, Journal of Fungi CrossRef
7. Drug Resistance in Pneumocystis jirovecii
   Jannik Helweg-Larsen et al, 2017, Antimicrobial Drug Resistance CrossRef
8. Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China
   Mingli Zhu et al, 2020, PLOS ONE CrossRef